Prospective study on association between endoscopic hematin findings and gastric acidity
Not Applicable
- Conditions
- Screening upper endoscopy
- Registration Number
- JPRN-UMIN000040962
- Lead Sponsor
- Oita Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 325
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who started or stopped taking antacid within the last 7 days including the date of endoscopic examination. 2.Patients with serious underlying diseases (cirrhosis/end stage renal failure) 3.Patients with a history of gastrectomy 4.4. Patients with mental illness or symptoms who may have difficulty participating in the study. 5.Other patients who are deemed inappropriate for the trial responsible physician or the test sharing doctor to conduct this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between the presence of hematin and fasting gastric juice pH
- Secondary Outcome Measures
Name Time Method The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of endoscopic hematin for predicting strong acidity